Shopping Cart
- Remove All
Your shopping cart is currently empty
Tankyrase Inhibitors 49 is an effective, selective, and orally bioavailable inhibitor of tankyrase (IC50: 0.1nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $189 | 6-8 weeks | |
| 10 mg | $329 | 6-8 weeks | |
| 50 mg | $888 | 6-8 weeks | |
| 100 mg | $1,400 | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $273 | 6-8 weeks |
| Description | Tankyrase Inhibitors 49 is an effective, selective, and orally bioavailable inhibitor of tankyrase (IC50: 0.1nM). |
| In vitro | Tankyrase inhibitors 49 is an optimization of the previous hit compound inhibitor 8 with improved potency and selectivity. It has excellent effects in both tankyrase assay and cellular assay (IC50: 0.1nM and 1.9nM, respectively). In addition, it is found to be a dual binder with both the nicotinamide pocket and the induced pocket of the enzymes [1]. |
| In vivo | In the in vivo studies in rodents, tankyrase inhibitors 49 is found to potently inhibit TNKS2 autoparsylation ( IC50: 7.6nM). It also causes stabilization and accumulation of axin protein in SW480 cells (EC50: 4nM). In DLD-1 cells with truncated APC, the inhibitor inhibits the STF reporter transcription ( IC50: 0.3nM) suggesting its downstream inhibitory activity on Wnt-associated transcription [1]. |
| Molecular Weight | 448.54 |
| Formula | C24H24N4O3S |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: ≥22.45 mg/mL, Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.